HighTower Advisors, LLC - ONCONOVA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of ONCONOVA THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$11,000
-35.3%
18,2780.0%0.00%
Q4 2015$17,000
-32.0%
18,2780.0%0.00%
Q3 2015$25,000
-41.9%
18,2780.0%0.00%
-100.0%
Q2 2015$43,000
-2.3%
18,2780.0%0.00%0.0%
Q1 2015$44,000
-26.7%
18,2780.0%0.00%0.0%
Q4 2014$60,000
-52.0%
18,278
-37.1%
0.00%
-50.0%
Q3 2014$125,000
+26.3%
29,055
+59.0%
0.00%0.0%
Q2 2014$99,000
-14.7%
18,2780.0%0.00%0.0%
Q1 2014$116,00018,278
-52.2%
0.00%
Q4 2013$038,2780.00%
Other shareholders
ONCONOVA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 120,000$1,378,0000.38%
EMERALD ADVISERS, LLC 367,369$4,217,0000.23%
WEATHERBIE CAPITAL, LLC 176,462$2,026,0000.19%
Catalyst Capital Advisors LLC 25,000$287,0000.09%
Eventide Asset Management 23,000$264,0000.08%
Weiss Multi-Strategy Advisers LLC 204,400$2,347,0000.05%
A.R.T. Advisors, LLC 42,741$490,0000.03%
KINGS POINT CAPITAL MANAGEMENT 5,500$63,0000.02%
SSI INVESTMENT MANAGEMENT LLC 21,470$247,0000.02%
Marshall Wace North America L.P. 14,439$166,0000.00%
View complete list of ONCONOVA THERAPEUTICS INC shareholders